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Background. Besides the extensive regulatory role in growing number of biologic processes, vitamin D has been recently considered
essential for lungs function as well as protective against exacerbation of chronic obstructive pulmonary diseases. We assessed the
correlation between vitamin D serum levels with pulmonary function in healthy individuals. Methods. In a cross-sectional study,
healthy volunteer (𝑛 = 92) participants underwent the following laboratory procedures: a blood test, a 24-hour urine collection
test, and the serum level of 25-hydroxy vitamin D before undergoing spirometry. Linear correlation coefficient was calculated to
detect the association between serum level of 25-hydroxy vitamin D and pulmonary volumes. Results. Themean age of participants
was 39.95 ± 9.98 years. 48% of participants showed different levels of 25-hydroxy vitamin D deficiency. We recognized a consistent
direct positive correlation between serum levels of 25-hydroxy vitaminD and lung function volumes.The coefficient for forced vital
capacity, forced expiratory volume in 1 second, forced expiratory flow 25–75%, and forced expiratory volume in 1 second/forced
vital capacity ratio were 0.610, 0.509, 0.454, and 0.551, respectively. Conclusions. Our findings suggest correlation between higher
serum levels of 25-hydroxy vitaminD and improved pulmonary function. Accordingly, supplemental vitaminDmight significantly
improve treatment response.
1. Introduction
Vitamin D is a fat-soluble vitamin extensively being consid-
ered for its essential role in calcium homeostasis and bone
formation. The serum level of vitamin D is a regulated by
exposure to the sunlight as well as dietary intake [1, 2].
VitaminD, however, has attracted remarkable attention for its
role in diverse biologic processes during past years, including
antiproliferative and antiapoptotic effect [3–5], prevention
from cardiovascular diseases [2, 3], modulating immunity
[4, 5], preventing autoimmune diseases (multiple sclerosis,
diabetes, rheumatoid arthritis, systemic lupus erythematosus,
etc.) [5–9], and expression of antimicrobial peptides and
receptors [10–14]. The role of vitamin D in the respiratory
infections prevention and treatment (particularly tubercu-
losis) has already been well-established [10–13]. The list of
suggested roles for vitamin D is still growing; for example,
studies have been linking psychosis to vitamin D deficiency
[15, 16].
Recent studies have proposed a relationship between
serum vitamin D level and the lungs function in both adult
and children [17–19]. Moreover, papers have indicated that
consumption of vitaminD supplements could protect against
moderate to severe exacerbation of chronic obstructive pul-
monary diseases (COPD) [20, 21], whereas some researchers
believe that those beneficial effects have been demonstrated
in vitro rather than in vivo and real life reports have been
conflicting [22].
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Despite the global prevalence of vitamin D deficiency
[23–25] and the reported correlation of vitamin D level
and COPD, only few studies have investigated association
between pulmonary function test in healthy individuals
and vitamin D level. Such study can better improve our
understanding of the controversy regarding protective effects
of vitamin D on the pulmonary system. This study is to
evaluate the correlation between vitamin D serum levels with
pulmonary volumes in healthy individuals.
2. Materials and Methods
Study Population. In this cross-sectional study, we recruited
healthy volunteers with negative history of pulmonary,
cardiovascular, and muscular diseases who responded to
a posted advertisement during a one-year study period.
The exclusion criteria were receiving therapeutic dosage of
vitamin D during the preceding 6 months, respiratory tract
infections (either lower or upper, regardless of being viral or
bacterial) during 8 weeks prior to the study, administration of
bronchodilators (beta-agonists, anticholinergics, inhaled and
systemic corticosteroids, andmethylxanthines) within 7 days
before the study, and smoking ≥ 20 pack-year.
Demographic data, including age, gender, height, weight,
and body mass index (BMI), were recorded for all enrolled
participants. Participants were asked to undergo laboratory
procedures that comprised (1) a blood work: 10 milliliter of
brachial venous blood was sampled for calcium, phosphorus,
alkaline phosphatase, 25-hydroxy vitamin D (25(OH)D),
blood urea nitrogen (BUN), creatinine (Cr), and parathyroid
hormone (parathormone), and (2) a 24-hour urine collection
test for calcium, phosphorus, creatinine, and urine volume.
The serum level of 25(OH)D was assessed by enzyme-
linked immunosorbent assay (ELISA) method. After lab-
oratory procedures, all participants underwent spirometry
for forced vital capacity (FVC), forced expiratory volume
in 1 second (FEV1), FEV1/FVC ratio, and forced expiratory
flow 25–75% (maximum mid-expiratory flow, FEF25–75%).
Pulmonary function test measured the amount of air that
participant breathes in and out. The person sat in front of
a spirometer and was fitted with a mouthpiece and wore a
nose clip so that all the air goes into the spirometer. The
technologist asked the person to breathe in and out as deeply
or as quickly as they can for several seconds. One expert
technologist measured the pulmonary function in present
study.
Cochran’s sample size formula was used in alpha error =
5% and Beta error = 20% and sample power was 80%.
Ethics Approval and Consent. The protocol of the present
study was approved by TehranUniversity ofMedical Sciences
under registered number 16419 in 2012. Bioethics committee
of the Tehran University of Medical Sciences approved the
study protocol. Participants’ consent was obtained through
signing a written informed consent form.
Statistical Analysis. For qualitative variables, absolute and rel-
ative frequency, and, for quantitative variables, themeanwith
two standard deviations were calculated. Linear correlation
Table 1: Age distribution of healthy participants.
Age group (year) 𝑁 (%)
25–30 5 (5.40)
30–35 11 (11.90)
35–40 25 (27.17)
40–45 23 (25.00)
45–50 18 (19.56)
50–55 6 (6.52)
55–60 1 (4.34)
coefficient was calculated to detect the association between
serum level of 25(OH)D and pulmonary volumes. The anal-
ysis was conducted with SPSS ver. 19 (IBM Corp., USA) and
𝑃 value < 0.05 was considered statistically significant.
3. Results
Thirty subjects out of ninety-two enrolled participant were
male (32.60%). The mean age of participants (spanned 25
to 60 years) was 39.95 (±9.98) years. Age distribution of
participants was shown in Table 1.
The mean of participants’ height and weight was 165.64
(±7.02) cm and 68.2 (±9.51) kg, respectively. Accordingly, the
mean BMI was 24.29 (±3.85) kg/m2, ranging from 16 to
32 kg/m2.The results of participants’ blood and 24-hour urine
samples are summarized in Table 2. No calcium and phos-
phorus disturbance was detected, nor was renal insufficiency
diagnosed. Table 3 represents serum levels of 25(OH) D
of the participants matched with reference values. Table 4
delineates the results of participants’ spirometry in terms of
four measured indices.
Calculating linear correlation coefficient for association
between serum level of 25(OH) D and pulmonary volumes
indicated a consistent direct positive correlation between
serum levels of 25(OH)D and lung function volumes. The
coefficients for FVC, FEV1, FEF25–75%, and FEV1/FVC ratio
were 0.610, 0.509, 0.454, and 0.551, respectively. Figure 1
depicts such a correlation for all four indices. Also, after
adjusting for age, gender, and BMI, the results showed
correlations for FVC, FEV1, FEF25–75%, and FEV1/FVC ratio
were 0.654, 0.515, 0.615, and 0.612, respectively.
4. Discussion
The authors of this study recruited only healthy individuals
to shed light on the preventive role of vitamin D and its
baseline status. The results of the present study emphasize
a positive correlation between the serum level of 25(OH)D
and pulmonary function. Although relationship of vitamin
D with respiratory tract infections has already been studied,
its association with normal pulmonary volumes has not been
under the spotlight so far.
In one of such few studies, Palacios and Gonzalez per-
formed spirometry on 14,000 people over 20 years old and
postulated a strong relationship between the average serum
concentrations of 25(OH)D and the average FEV1 and FVC
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Table 2: Healthy participants’ blood and 24-hour urine samples studied for association between serum 25(OH)D and pulmonary volumes.
Variable Mean (±SD∗) Normal reference
Blood chemistry
BUN† 24.67 (±3.20) 18–55 (mg/dl)‡
Creatinine 0.80 (±0.19) 0.7–1.4 (mg/dl)
Calcium 8.70 (±0.23) 8.5–10.2 (mg/dl)
Phosphorus 3.40 (±0.60) 2.4–4.5 (mg/dl)
Alkaline phosphatase 74 (±11.04) 35–100 (U/L)§
Parathyroid hormone 32.22 (±13.28) 11–54 (pg/ml)¶
24-hour urine analysis
Total volume 1772.83 (±476.97) 800–2000 (ml/24 h)
Creatinine 1122.11 (±412.05) 500–2000 (mg/24 h)
Calcium 136.34 (±96.01) 100–250 (mg/24 h)
Phosphorus 545.40 (±111.25) 400–1300 (mg/24 h)
∗SD, standard deviation; †BUN, blood urea nitrogen; ‡mg/dl, milligram per deciliter; §U/L, unit per liter; ¶pg/ml, picogram per milliliter.
Table 3: Distribution of the matched levels of 25(OH)D for the studied healthy individuals.
Variable Number (%) Normal reference (ng/ml)∗
25(OH)D
Sufficient 48 (52.20) 30–100
Insufficient 8 (8.70) 20–30
Deficient 25 (27.20) 10–20
Very deficient 11 (12.00) <10
∗ng/ml, nanogram per milliliter.
volumes (𝑃 < 0.001) [24]. This finding is consistent with our
finding in the present study.
Other studies have concluded that decreased serum level
of vitamin D has been associated with pulmonary dysfunc-
tion, increased airway hyperresponsiveness, and reduced
therapeutic response to glucocorticoids suggesting that sup-
plemental vitamin D for an improved treatment response
would be likely justifiable [26]. This conclusion is in accor-
dance with our finding that higher serum vitamin D levels
correlate with healthier respiratory volumes. Sutherland and
colleagues pointed out that for every one nanogram/milliliter
increase in vitamin D serum concentration, FEV1 would
experience 22.7 (±9.3) milliliter increments. In another study,
a 6-month follow-up of 25(OH)D baseline in 800 Finnish
young adults revealed that serum 25(OH)D level lower than
40 nanomol/liter was significantly associated with more sick
leaves due to respiratory tract infections (𝑃 = 0.004) [27].
Li et al. found that low serum vitamin D was associated with
lower lung function in Chinese asthma patients [28].
Themean of serum 25(OH)D level in the aforementioned
study was 80.2 (±29.3) nanomol/liter. In addition, the dis-
crepancy of 25(OH)D serum level between smoker cases and
nonsmoker controls was statistically significant (𝑃 < 0.001).
In our study, we excluded smokers in order to evaluate
the net effect of serum vitamin D on lung volumes; though
this rendered comparison between smokers and nonsmokers
impossible.The authors recommend further investigations to
determine if serum 25(OH)D levels in healthy individuals
is of prognostic value for upcoming pulmonary/respiratory
disorders. We also recommend studying lung volumes in
people with vitamin D deficiency in order to help better
understand the impact of vitamin D on respiratory tract.
5. Conclusions
The results of our study indicate that higher serum levels of
25-hydroxy vitamin D correlate with improved pulmonary
function capabilities. Therefore vitamin D supplementation
may be useful for improving pulmonary function capabilities.
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Table 4: The results of healthy participants’ spirometry tests.
Lung function index Measured lung function(mean ± SD) Predicted lung function (%)
FVC∗ (Lit) 2.60 (±0.47) 88.27 (2.41)
FEV1† (Lit) 2.10 (±0.51) 89.41 (1.05)
FEF25–75%
‡ (Lit/S) 3.33 (±0.55) 106.64 (3.71)
FEV1/FVC 91.41 (±3.64) 112.87 (5.89)
∗FVC, forced vital capacity; †FEV1, forced expiratory volume in 1 second; ‡FEF25–75%, maximummid-expiratory flow or forced expiratory flow 25–75%. All
four spirometry indices were measured as liter (Lit), except for forced expiratory flow (FEF) that was measured as liter per second (Lit/S) and represented as
mean (±SD).
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Figure 1: Positive correlation of the serum 25(OH)D with indices of spirometry test in healthy individuals. FVC, forced vital capacity; FEV1,
forced expiratory volume in 1 second; FEF25–75%, maximum mid-expiratory flow or forced expiratory flow 25–75%.
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